Genmab A/S (GMAB)
31.33
+0.40
(+1.29%)
USD |
NASDAQ |
Dec 10, 15:49
Genmab Profit Margin (Quarterly): 39.24% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merus NV | -786.2% |
| Johnson & Johnson | 21.47% |
| Novo Nordisk A/S | 26.68% |
| Ascendis Pharma A/S | -28.55% |
| Evaxion AS | -2.98K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 28.30% |
| Return on Assets | 22.93% |
| Return on Invested Capital | 27.54% |
| Gross Profit Margin (Quarterly) | 94.32% |
| Operating Margin (Quarterly) | 44.91% |
| Return on Net Operating Assets | 44.78% |